Notably, MSC therapies for uterine adhesions and early-onset ovarian failure have progressed to clinical application, demonstrating notable efficacy
Who Should Consider It Anyone with elevated toxin burden (heavy metal exposure, mycotoxin illness, chemical sensitivities) requiring enhanced Phase II detox capacity Individuals undergoing structured detoxification protocols where adequate GSH conjugation capacity is critical Those with chronic illness, autoimmune conditions, or persistent inflammation associated with oxidative stress and GSH depletion Biohackers focused on mitochondrial health, longevity, and cellular redox optimisation High-performance athletes experiencing high oxidative stress from training load Anyone with a history of significant pharmaceutical exposure (statins, acetaminophen, and many other drugs deplete hepatic GSH) Ready to upgrade your antioxidant foundation
Shi Y, Wang D, Lu L, Yin Y, Wang M, Li C, Diao J, Wang Y, Wei L
Don't get me wrong